Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Launch imminent for Fujisawa's new treatment of atopic dermatitis

Nov. 22, 1999

Allergan establishes agreement with 3M for Tazorac

Nov. 22, 1999

AxyS discontinues further development of APC-2059 in psoriasis

Nov. 19, 1999

Small patient study indicates potential new indication for leflunomide

Nov. 17, 1999

FDA accepts NDA for tacrolimus ointment

Nov. 16, 1999

Chromanone derivatives for androgen-dependent and other disorders disclosed by Novartis

Nov. 16, 1999

FDA authorizes OrthoLogic to proceed with Chrysalin trials in fracture healing

Nov. 16, 1999

Candidate treatment for atopic dermatitis presented at Japanese congress

Nov. 2, 1999

PDE4-inhbitory pyridines disclosed by Janssen

Oct. 27, 1999

Polyethoxylated retinamides superior to known retinoic acid derivatives for skin aging

Oct. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...